サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：禁煙・脱ニコチン中毒の世界市場：2023～2030年
市場調査レポート
商品コード
1380449

禁煙・脱ニコチン中毒の世界市場：2023～2030年

Global Smoking Cessation and Nicotine De-addiction Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 195 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
禁煙・脱ニコチン中毒の世界市場：2023～2030年
出版日: 2023年10月01日
発行: Orion Market Research
ページ情報: 英文 195 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の禁煙・脱ニコチン中毒市場は予測期間中にCAGR 15.2％で成長すると予測されます。禁煙・脱ニコチン中毒市場は、肺がん、心臓疾患、その他の呼吸器疾患などの喫煙による健康上の不利益、情報パンフレット、警告ラベル、タバコのパッケージの禁煙イメージ、テレビ広告、新聞などの利用を通じて喫煙の有害な影響についての認識を高めるための政府によるイニシアティブの支援により、大きな成長を遂げています。

セグメント別の展望

世界の禁煙・脱ニコチン中毒市場はNTRサブセグメントが大きなシェアを占めると予測される

タイプの中では、NTRサブセグメントが、その使いやすさ、入手しやすさ、喫煙者のニコチン渇望を抑える有効性から、市場で突出したシェアを占めると予想されます。NTRは、ガム、パッチ、スプレー、吸入器、トローチの形でニコチンを摂取させるが、タバコに含まれる他の有害な化学物質は摂取させないです。NRTは身体的な禁断症状を和らげ、禁煙の心理的（感情的）な側面に集中できるようにします。WHOによると、タバコは世界の公衆衛生にとって最大の害であり、年間800万人以上が死亡しています。このうち約130万人は非喫煙者が副流煙にさらされることで死亡しており、700万人以上はタバコを直接使用することで死亡しています。NRT製品は禁煙に有効であり、禁煙に悩む喫煙者の間で広く使用されています。2017年から2020年にかけて、市販のNTRの売上は年間約10億米ドルでした。2020年には、市販のニコチン置換療法売上高の33.3％（3億2,200万米ドル）、ガムが52.7％（5億1,100万米ドル）、パッチが14.1％（1億3,700万米ドル）を占めました。市販のニコチン置換療法売上高に占めるドラッグストアの割合が最も高くなりました（42.9％）。

地域別展望

世界の禁煙・脱ニコチン中毒市場は、北米（米国、カナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の中東・アフリカ（中東およびアフリカ、ラテンアメリカ）の地域別にさらに細分化されています。このうち、欧州地域市場は予測期間中に大きく成長すると予想されます。ニコチン含有OTC禁煙補助剤は、英国などの国々で最も好まれるニコチン代替療法（NRT）製品です。欧州市場は、禁煙の利点に対する一般市民の意識の高まりと禁煙プログラムの増加によって牽引されています。

北米が世界の禁煙・脱ニコチン中毒で圧倒的なシェアを占める見込み

北米は、医療インフラが発達していることに加え、裁量的支出に充てられる所得が増加していることから、禁煙・脱ニコチン中毒市場を独占しています。米国医師会（AMA）によると、米国の医療支出は2020年に9.7％増加し、4兆1,000億ドル、国民1人当たり1万2,530ドルに達します。電子タバコ製品に対する地域の旺盛な需要もまた、北米における禁煙とニコチン除去市場の拡大に大きな役割を果たしました。電子タバコは2番目によく使用されるタバコ製品であり、米国の成人の4.5％（1,090万人）が2019年に同製品の使用を報告しました。各国で植物由来のニコチン脱中毒関連製品の利用へと消費者の嗜好がシフトしていることから、北米地域はかなりの割合で拡大すると予測されます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリスト洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Johnson & Johnson Services, Inc.
  • Pfizer, Inc.
  • Cipla Inc.
  • 主要戦略分析

第4章 市場セグメンテーション

  • 禁煙・脱ニコチン中毒の世界市場：タイプ別
    • ニコチン代替療法（NRT）
    • 薬物療法
    • 電子タバコ
  • 禁煙・脱ニコチン中毒の世界市場：流通チャネル別
    • 病院薬局
    • ドラッグストア
    • 小売店
    • オンラインストア

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • 世界のその他の中東・アフリカ

第6章 企業プロファイル

  • British American Tobacco Plc
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline Plc
  • Imperial Brands Plc
  • Japan Tobacco, Inc.
  • JUUL Labs, Inc.
  • Philip Morris International Inc.
  • Niconovum AB
  • Perrigo Company plc,
  • OncoGenex Pharmaceuticals, Inc.
  • NJOY, LLC
  • Vaping Daily
  • InnokinTechnology
  • Snowplus
  • Ritchy group Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPES, 2022-2030 ($ MILLION)
  • 2. GLOBAL NTR SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL DRUG THERAPY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL E-CIGARETTES SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY DRUG STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY RETAIL STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY ONLINE STORES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 14. EUROPEAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. EUROPEAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. EUROPEAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. ASIA- PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL NTR SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL DRUG THERAPY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL E-CIGARETTES SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 6. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY HOSPITALS PHARMACIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY DRUG STORES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY RETAIL STORES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION BY ONLINE STORES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. US SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. CANADA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. UK SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. FRANCE SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. GERMANY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. SPAIN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. REST OF EUROPE SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. INDIA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CHINA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. JAPAN SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SOUTH KOREA SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF THE WORLD SMOKING CESSATION AND NICOTINE DE-ADDICTION MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027738

Title: Global Smoking Cessation and Nicotine De-Addiction Market Size, Share & Trends Analysis Report by Types (Nicotine Replacement Therapy (NRT), Drug Therapy, and E-Cigarettes), and by Distribution Channel (Hospitals Pharmacies, Drug Stores, Retail Stores, and Online Stores)Forecast Period (2023-2030).

Global smoking cessation and nicotine de-addiction market is anticipated to grow at a CAGR of 15.2 % during the forecast period. The smoking cessation and nicotine de-addiction market has witnessed significant growth due to health disadvantages of smoking such as lung cancer, cardiac diseases, and other respiratory problems, initiatives supported by governments to raise awareness about the harmful effects of smoking through the use of informational brochures, warning labels, dissuasive imagery on cigarette packages, television advertisements, and newspapers.

Segmental Outlook

The global smoking cessation and nicotine de-addiction market is segmented based on the type, and distribution channel. Based on the type, the market is sub-segmented into NTR, drug therapy, e-cigarettes. Based on distribution channel, the market is sub-segmented into hospitals pharmacies, drug stores, retail stores and online stores. Among the distribution channel, the hospitals pharmacies sub-segment is anticipated to hold a considerable share of the market due to good assurance of product standards and consumer trust. In most countries, sales of nicotine gum and other nicotine replacement products are restricted to pharmacy shops.

NTR Sub-Segment is Anticipated to Hold a Prominent Share in the Global Smoking cessation and nicotine de-addiction Market

Among the types, NTR sub-segment is anticipated to hold a prominent share of the market due to its ease of use, its increased accessibility, and its effectiveness in reducing the nicotine craving in smokers. NTR gives individual nicotine in the form of gum, patches, sprays, inhalers, or lozenges but not the other harmful chemicals in tobacco. NRT can help relieve some of the physical withdrawal symptoms so that you can focus on the psychological (emotional) aspects of quitting. According to WHO tobacco epidemic the greatest hazards to global public health, killing more than 8 million people annually. Around 1.3 million of those fatalities are caused by non-smokers being exposed to secondhand smoke, whereas more than 7 million are caused by direct tobacco use. NRT products have been effective in helping people quit smoking and are widely used among smokers struggling to quit. Between 2017 and 2020 over-the-counter NTR sales totaled about $1 billion annually. In 2020, lozenges accounted for 33.3 per cent ($322 million), gum accounted for 52.7% ($511 million) and patches accounted for 14.1% ($137 million) of over-the-counter nicotine replacement therapy sales. Drug stores were accounting for the largest percentage of total over-the-counter nicotine replacement therapy sales (42.9%).

Regional Outlook

The global smoking cessation and nicotine de-addiction market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Europe regional market is expected to grow considerably over the forecast period. Nicotine-containing OTC smoking cessation products are the most preferred nicotine replacement therapy (NRT) products in the countries such as UK. The market in Europe is being driven by increased public awareness of the advantages of quitting smoking and a rise in the number of smoking cessations programmes.

North America is Expected to Hold a Prominent Share in the Global Smoking cessation and nicotine de-addiction

North America is dominating the smoking cessation and nicotine de-addiction market, due to the developed healthcare infrastructure as well as the growing incomes available for discretionary spending. According to the American Medical Association (AMA), health spending in the US increased by 9.7% in 2020 and reached to $4.1 trillion or $12,530 per capita. Region's strong demand for e-cigarette products also played a major role in increasing smoking cessation and nicotine de-addiction market in North America. E-cigarettes were the second most commonly used tobacco product, with 4.5% (10.9 million) of the US adults reporting use of the product in 2019. It is anticipated that the North American region will expand at a significant rate due to the shifting preferences of consumers towards the utilization of plant-based, nicotine de-addiction-related products in countries.

Market Players Outlook

The major companies serving the global smoking cessation and nicotine de-addiction market include: British American Tobacco Plc, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Imperial Brands Plc, Japan Tobacco, Inc., JUUL Labs, Inc., Philip Morris International Inc., Niconovum AB, Perrigo Company plc, OncoGenex Pharmaceuticals Inc, NJOY, LLC, InnokinTechnology and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2020, Nicotex, Cipla Health's smoking cessation brand, collaborated with Karnataka and Goa governments to provide Nicotine Replacement Therapy (NRT) to frontline workers, who are engaged in field work under high vulnerability amidst the COVID-19 outbreak.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global smoking cessation and nicotine de-addiction market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Johnson & Johnson Services, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Pfizer, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Cipla Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Smoking Cessation and Nicotine De-addiction Market by Types
    • 4.1.1. Nicotine Replacement Therapy (NRT)
    • 4.1.2. Drug Therapy
    • 4.1.3. E-Cigarettes
  • 4.2. Global Smoking Cessation and Nicotine De-addiction Market by Distribution Channel
    • 4.2.1. Hospitals Pharmacies
    • 4.2.2. Drug Stores
    • 4.2.3. Retail Stores
    • 4.2.4. Online Stores

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. British American Tobacco Plc
  • 6.2. Dr. Reddy's Laboratories Ltd.
  • 6.3. GlaxoSmithKline Plc
  • 6.4. Imperial Brands Plc
  • 6.5. Japan Tobacco, Inc.
  • 6.6. JUUL Labs, Inc.
  • 6.7. Philip Morris International Inc.
  • 6.8. Niconovum AB
  • 6.9. Perrigo Company plc,
  • 6.10. OncoGenex Pharmaceuticals, Inc.
  • 6.11. NJOY, LLC
  • 6.12. Vaping Daily
  • 6.13. InnokinTechnology
  • 6.14. Snowplus
  • 6.15. Ritchy group Ltd.